[1] D'Cruz OJ, Uckun FM. Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07)[J]. J Antimicrob Chemother, 2002, 50(6): 793-803. [2] Ayehunie S, Cannon C, Larosa K, et al.Development of an in vitro alternative assay method for vaginal irritation[J]. Toxicology, 2011, 279(1-3):130-138. [3] Squier CA, Mantz MJ, Schlievert PM, et al.Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa[J]. J Pharm Sci, 2008, 97(1):9-21. [4] D'Cruz OJ, Uckun FM. Preclinical evaluation of a dual-acting microbicidal prodrug WHI-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat[J]. Toxicol Pathol, 2007, 35(7):910-927. [5] D'Cruz OJ, Uckun FM. Evaluation of local tolerance of the antiretroviral spermicide (WHI-07)-loaded gel-microemulsion in the porcine female reproductive tract[J]. J Appl Toxicol, 2008, 28(3):303-314. [6] D'Cruz OJ, Erbeck D, Uckun FM. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate[J]. Toxicol Pathol, 2005, 33(4): 465-476. [7] Quinn TC, Overbaugh J.HIV/AIDS in women: an expanding epidemic[J]. Science, 2005, 308(5728):1582-1583. [8] Cutler B, Justman J.Vaginal microbicides and the prevention of HIV transmission[J]. Lancet Infect Dis, 2008, 8(11):685-697. [9] Li WH.The research and development progress of double function topical contraceptive[J]. Reprod & Contracep (In Chinese) 2011, 31(11):761-764. [10] Trifonova RT, Bajpai M, Pasicznyk JM, et al.Biomarkers of leukocyte traffic and activation in the vaginal mucosa[J]. Biomarkers, 2007, 12(6):608-622. [11] Jain JK, Li A, Nucatola DL, et al.Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways[J]. Biol Reprod, 2005, 73(2):382-388. [12] Catalone BJ, Kish-Catalone TM, Budgeon LR, et al.Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides[J]. Antimicrob Agents Chemother, 2004, 48(5):1837-1847. |